Ian McGovern

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 27

Top Topics

Systematic Review

Infectious Diseases

Stem Cell Transplantation

Top Venues

Open forum infectious diseases

Influenza and other respiratory viruses

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

This page only lists publications with an associated author ORCID identifier.

Publications

Alicia N Stein, Carrie W Mills, Ian McGovern, Kimberly W McDermott, Alex Dean, Alina N Bogdanov, Sheena G Sullivan, Mendel D M Haag
Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States. Open forum infectious diseases 11 (5) (2024)
Ian McGovern, Katherine Cappell, Alina N Bogdanov, Mendel D M Haag
Incidence of Influenza-Related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in The United States During the 2015-2020 Influenza Seasons. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Ian McGovern, Katherine Cappell, Alina N Bogdanov, Mendel D M Haag
Number of Influenza Risk Factors Informs an Adult's Increased Potential of Severe Influenza Outcomes: A Multiseason Cohort Study From 2015 to 2020. Open forum infectious diseases 11 (5) (2024)
Ian McGovern, Katherine Cappell, Alina N Bogdanov, Mendel D M Haag
Number of Influenza Risk Factors Informs an Adult's Increased Potential of Severe Influenza Outcomes: A Multiseason Cohort Study From 2015 to 2020. Open forum infectious diseases 11 (5) (2024)
Mahrukh Imran, Carrie W Mills, Kimberly W McDermott, Alex Dean, Alina Bogdanov, Ian McGovern, Mendel D M Haag
Relative Effectiveness of the MF59-Adjuvanted Influenza Vaccine Versus High-Dose Influenza Vaccine in Older Adults With Influenza Risk Factors During the 2019-2020 US Influenza Season. Open forum infectious diseases 11 (8) (2024)
Roeland Christiaan Alfons Achterbergh, Ian McGovern, Mendel D M Haag
Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023. Vaccines 12 (2) (2024)
Mahrukh Imran, Carrie W Mills, Kimberly W McDermott, Alex Dean, Alina Bogdanov, Ian McGovern, Mendel D M Haag
Relative Effectiveness of the MF59-Adjuvanted Influenza Vaccine Versus High-Dose Influenza Vaccine in Older Adults With Influenza Risk Factors During the 2019-2020 US Influenza Season. Open forum infectious diseases 11 (8) (2024)
Roeland Christiaan Alfons Achterbergh, Ian McGovern, Mendel D M Haag
Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023. Vaccines 12 (2) (2024)
Alicia N Stein, Carrie W Mills, Ian McGovern, Kimberly W McDermott, Alex Dean, Alina N Bogdanov, Sheena G Sullivan, Mendel D M Haag
Relative Vaccine Effectiveness of Cell- vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States. Open forum infectious diseases 11 (5) (2024)
Brenda L Coleman, Iris Gutmanis, Ian McGovern, Mendel D M Haag
Effectiveness of Cell-Based Quadrivalent Seasonal Influenza Vaccine: A Systematic Review and Meta-Analysis. Vaccines 11 (10) (2023)
Ian McGovern, Aditya Sardesai, Alexandra Taylor, Hector Toro-Diaz, Mendel Haag
Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years. Open forum infectious diseases 10 (8) (2023)
Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, John Youhanna
Correction: Rockman et al. Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines 2023, 11 , 52. Vaccines 11 (12) (2023)
Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, John Youhanna
Correction: Rockman et al. Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines 2023, 11 , 52. Vaccines 11 (12) (2023)
Patrizio Zanobini, Guglielmo Bonaccorsi, Chiara Lorini, Mendel Haag, Ian McGovern, John Paget, Saverio Caini
Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020. Influenza and other respiratory viruses 16 (4) (2022)
Anke L Stuurman, Miriam Levi, Philippe Beutels, Hélène Bricout, Alexandre Descamps, Gaël Dos Santos, Ian McGovern, Ainara Mira-Iglesias, Jos Nauta, Laurence Torcel-Pagnon, Jorne Biccler, null null
Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project. Influenza and other respiratory viruses (2022)
Analía Urueña, Paula Micone, María Cecilia Magneres, Ian McGovern, Joaquin F Mould-Quevedo, Túlio Tadeu Rocha Sarmento, Norberto Giglio
Cost-Effectiveness Analysis of Cell Versus Egg-Based Seasonal Influenza Vaccination in Children and Adults in Argentina. Vaccines 10 (10) (2022)
Anke L Stuurman, Miriam Levi, Philippe Beutels, Hélène Bricout, Alexandre Descamps, Gaël Dos Santos, Ian McGovern, Ainara Mira-Iglesias, Jos Nauta, Laurence Torcel-Pagnon, Jorne Biccler, null null
Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project. Influenza and other respiratory viruses 17 (1) (2022)
Ian McGovern, Alina Bogdanov, Katherine Cappell, Sam Whipple, Mendel Haag
Influenza Vaccine Uptake in the United States before and during the COVID-19 Pandemic. Vaccines 10 (10) (2022)
Anke L Stuurman, Miriam Levi, Philippe Beutels, Hélène Bricout, Alexandre Descamps, Gaël Dos Santos, Ian McGovern, Ainara Mira-Iglesias, Jos Nauta, Laurence Torcel-Pagnon, Jorne Biccler, null null
Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project. Influenza and other respiratory viruses 17 (1) (2022)
Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, John Youhanna
Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines 11 (1) (2022)
Anke L Stuurman, Miriam Levi, Philippe Beutels, Hélène Bricout, Alexandre Descamps, Gaël Dos Santos, Ian McGovern, Ainara Mira-Iglesias, Jos Nauta, Laurence Torcel-Pagnon, Jorne Biccler, null null
Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project. Influenza and other respiratory viruses (2022)
Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, John Youhanna
Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines 11 (1) (2022)
Constantina Boikos, Ian McGovern, Deborah Molrine, Justin R Ortiz, Joan Puig-Barbera, Mendel Haag
Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons. Vaccines 10 (6) (2022)
Constantina Boikos, Ian McGovern, Justin R Ortiz, Joan Puig-Barbera, Eve Versage, Mendel Haag
Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine over Three Consecutive Influenza Seasons in the United States. Vaccines 10 (9) (2022)
Anke L Stuurman, Miriam Levi, Philippe Beutels, Hélène Bricout, Alexandre Descamps, Gaël Dos Santos, Ian McGovern, Ainara Mira-Iglesias, Jos Nauta, Laurence Torcel-Pagnon, Jorne Biccler, null null
Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies-Experience from the DRIVE project. Influenza and other respiratory viruses 17 (1) (2022)
Steven Rockman, Karen Laurie, Chi Ong, Sankarasubramanian Rajaram, Ian McGovern, Vy Tran, John Youhanna
Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines 11 (1) (2022)
Brenda L Coleman, Ruth Sanderson, Mendel D M Haag, Ian McGovern
Reply to Letter to the Editor by Yin et al. Influenza and other respiratory viruses 15 (6) (2021)